Shares slid 6.9% to $36.00 after MDA Space unveiled a twin announcement late Wednesday: an approximately 70% acquisition of French satellite-data firm CLS for roughly €567 million (C$920 million) in cash , financed in part by a bought deal offering of 20,000,000 common shares at US$35.60 each for aggregate gross proceeds of US$712 million . The stock fell almost precisely to the offering price, signaling investors are repricing around the new, larger share base.
• Twenty Million New Shares Add Up to a Roughly 14% Bigger Pie. The company currently has about 139 million shares outstanding, meaning the new issue would represent a roughly 14-per-cent increase. On top of that, MDA granted the underwriters an over-allotment option to purchase up to an additional 15% of shares — potentially pushing the total new stock even higher. More shares outstanding means each existing share represents a smaller slice of future profits, which is exactly the "dilution" spooking holders today.
• The Prize: A Fast-Growing Data Business With 14,000 Customers. CLS is expected to generate approximately €286 million (C$465 million) in revenue in 2026 , translating to an average annual growth rate of 22% since 2023, with expected profit margins of 18–20% . MDA says the acquisition is expected to double its recurring revenue stream and be accretive to adjusted earnings per share within the first year. If that pans out, the dilution arithmetic could eventually work in shareholders' favor.
• The Cash Commitment Could Get Even Bigger. If CLS is unable to refinance its existing debt at closing, MDA would fund approximately €198 million to retire it. That contingent liability, on top of MDA's separate $620 million all-cash acquisition of Blue Canyon Technologies announced June 19 , raises the total M&A bill north of $1.5 billion in a matter of weeks. MDA expects to remain within its target leverage range of 1.5×–2.5× net debt to adjusted earnings after both deals close , but that leaves limited margin for error.
• The Offering and the Deal Aren't Linked — Creating Extra Uncertainty. Because the financing and the acquisition aren't conditional on each other, investors have to consider two separate questions: whether the CLS deal closes on schedule, and what MDA does with the cash if it doesn't.
Raising equity this far ahead of a deal can create a valuation overhang — the share count jumps right away, but the acquired business may not contribute for a long time. The deal isn't expected to close until late 2026 or early 2027.